相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants
Sarah K. Browne et al.
VACCINE (2020)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Stephen M. Kissler et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
Neeltje van Doremalen et al.
SCIENCE ADVANCES (2020)
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
Ruklanthi de Alwis et al.
EBIOMEDICINE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'
Enrico Lavezzo et al.
NATURE (2020)
Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital
Tristan Ramcharan et al.
PEDIATRIC CARDIOLOGY (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Huibin Lv et al.
CELL REPORTS (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
Roosecelis B. Martines et al.
EMERGING INFECTIOUS DISEASES (2020)
Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset
Emmie de Wit et al.
ANTIVIRAL RESEARCH (2019)
Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region
Isabel Rodriguez-Barraquer et al.
SCIENCE (2019)
Novel correlates of protection against pandemic H1N1 influenza A virus infection
Sophia Ng et al.
NATURE MEDICINE (2019)
Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics
Katie L. Winarski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Neonatal Fc Receptor (FcRn): A Misnomer?
Michal Pyzik et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
Sofia S. Aranda et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
Tracy J. Ruckwardt et al.
IMMUNITY (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Dengue vaccine: WHO position paper, September 2018-Recommendations
[Anonymous]
VACCINE (2019)
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
Emmie de Wit et al.
ANTIVIRAL RESEARCH (2018)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
Joseph B. Domachowske et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
Laura M. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Beyond binding: antibody effector functions in infectious diseases
Lenette L. Lu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Fcγ Receptor Function and the Design of Vaccination Strategies
Stylianos Bournazos et al.
IMMUNITY (2017)
IVIG-mediated effector functions in autoimmune and inflammatory diseases
Caroline Galeotti et al.
INTERNATIONAL IMMUNOLOGY (2017)
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Affinity of human IgG subclasses to mouse Fc gamma receptors
Gillian Dekkers et al.
MABS (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis
Louise E. Lansbury et al.
VACCINE (2017)
Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
Janne Tynell et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
Laura A. VanBlargan et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
Reed F. Johnson et al.
VIROLOGY (2016)
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
Kuan Rong Chan et al.
NATURE MICROBIOLOGY (2016)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
Jie Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
An update on feline infectious peritonitis: Virology and immunopathogenesis
Niels C. Pedersen
VETERINARY JOURNAL (2014)
Relationship of Preexisting Influenza Hemagglutination Inhibition, Complement-Dependent Lytic, and Antibody-Dependent Cellular Cytotoxicity Antibodies to the Development of Clinical Illness in a Prospective Study of A(H1N1)pdm09 Influenza in Children
Mary Dawn T. Co et al.
VIRAL IMMUNOLOGY (2014)
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Fumihiko Yasui et al.
VIROLOGY (2014)
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Ming Shum Yip et al.
VIROLOGY JOURNAL (2014)
Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
Ruklanthi de Alwis et al.
PLOS PATHOGENS (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Maria G. Guzman et al.
ARCHIVES OF VIROLOGY (2013)
Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
Craig Fett et al.
JOURNAL OF VIROLOGY (2013)
Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
Candice Clay et al.
JOURNAL OF VIROLOGY (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Patrick Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
Tohru Miyoshi-Akiyama et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
Ana Clara Monsalvo et al.
NATURE MEDICINE (2011)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Martina Beltramello et al.
CELL HOST & MICROBE (2010)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
Joseph T. Wu et al.
CLINICAL INFECTIOUS DISEASES (2010)
Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four Observational Studies from Canada
Danuta M. Skowronski et al.
PLOS MEDICINE (2010)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge
Barry Rockx et al.
JOURNAL OF VIROLOGY (2008)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine
E Qin et al.
VACCINE (2006)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Human coronavirus NL63, a new respiratory virus
Lia van der Hoek et al.
FEMS MICROBIOLOGY REVIEWS (2006)
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
LQ Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Intravenous immunoglobulin therapy and systemic lupus erythematosus
G Zandman-Goddard et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells
A Bergtold et al.
IMMUNITY (2005)
Neutralizing antibody response and SARS severity
MS Ho et al.
EMERGING INFECTIOUS DISEASES (2005)
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63
KH Chan et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys
J Zhou et al.
VACCINE (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
ZW Chen et al.
JOURNAL OF VIROLOGY (2005)
SARS-coronavirus replication in human peripheral monocytes/macrophages
M Yilla et al.
VIRUS RESEARCH (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Passive antibody therapy for infectious diseases
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
J ter Meulen et al.
LANCET (2004)
pH-dependent entry of Severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN
ZY Yang et al.
JOURNAL OF VIROLOGY (2004)
A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles
FP Polack et al.
NATURE MEDICINE (2003)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
